tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Holding TSHA?
Track your performance easily

Taysha Gene Therapies (TSHA) Financial Statements

934 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently ―. The company's EPS TTM is $-0.033; its P/E ratio is -95.58; Taysha Gene Therapies is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.79M$ 1.11M$ 3.41M$ 3.61M$ 4.75M
Gross Profit$ 1.79M$ 1.11M$ 3.41M$ 3.61M$ 4.75M
EBIT$ -24.22M$ -20.90M$ -22.64M$ 48.45M$ -115.62M
EBITDA$ -23.63M$ -20.26M$ -22.02M$ 48.82M$ -115.28M
Net Income Common Stockholders$ -25.52M$ -20.93M$ -24.06M$ 47.74M$ -117.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.70M$ 172.70M$ 124.00M$ 143.90M$ 164.30M
Total Assets$ 180.22M$ 200.39M$ 153.00M$ 172.73M$ 195.77M
Total Debt$ 60.72M$ 55.97M$ 59.01M$ 59.46M$ 57.65M
Net Debt$ -96.98M$ -116.73M$ -64.99M$ -84.44M$ -106.65M
Total Liabilities$ 91.42M$ 91.53M$ 99.15M$ 97.79M$ 244.88M
Stockholders Equity$ 88.80M$ 108.87M$ 53.85M$ 74.94M$ -49.11M
Cash Flow-
Free Cash Flow$ -21.65M$ -21.70M$ -19.94M$ -16.13M$ -21.45M
Operating Cash Flow$ -21.61M$ -21.50M$ -19.80M$ -16.12M$ -17.95M
Investing Cash Flow$ -35.00K$ -201.00K$ -140.00K$ -10.00K$ -3.49M
Financing Cash Flow$ 6.59M$ 70.47M$ -22.00K$ -4.25M$ 140.63M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Taysha Gene Therapies Debt to Assets

Taysha Gene Therapies Cash Flow

Taysha Gene Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis